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For  1-2  days  after  injection  of mice  (1,  2)  or  rats  (3)  with  heterologous 
erythrocytes or  hapten-protein  conjugates,  thoracic  duct  lymphocytes (TDL)  1 
become specifically depleted of lymphocytes reactive  to the  injected  antigen. 
The  spleen  at  this  time,  by contrast,  contains  normal  or increased  levels of 
specifically-reactive cells (ref. 4 and unpublished data of J.  Sprent and I. Lef- 
kovits). These data are interpreted in terms of antigen-induced selective recruit- 
ment  of recirculating  lymphocytes (ASRL) from the circulation  to regions of 
antigen concentration,  e.g., the spleen. 
Major histocompatibility determinants also appear to cause ASRL. Thus the 
capacity of TDL from parental-strain  mice (1) or rats (3) to induce graft-versus- 
host (GVH) reactions is specifically reduced or abolished 1-2 days after injection 
of F~  hybrid  spleen  cells.  Similar  results  have  been  obtained  by "filtering" 
parental-strain  TDL through irradiated F~ hybrid rats (5). 
A  variety  of assay systems  are  used to  measure  T-cell  responses to major 
histocompatibfiity determinants.  These include the mixed-lymphocyte reaction 
(MLR), GVH reaction, allograft rejection, and cell-mediated lympholysis (CML). 
In mice, it is generally considered that the H-2 determinants which control the 
MLR and GVH reactions are coded for predominantly by the I  region of the H.2 
complex, whereas allograft rejection and  CML are controlled largely by the K 
and D  regions (6-8).  This has led to the proposal that lymphocytes producing 
MLR and GVH reactions have a different specificity from those controlling CML 
and rejection of allografts (9). The present studies were designed to investigate 
whether  all  of these H-2-reactive  populations  undergo  selective  recruitment 
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during allostimulation in vivo. It will be shown that TDL from mice injected 1 
day previously  with  semiallogeneic  spleen  cells  are  almost  totally  devoid  of 
lymphocytes controlling  CML,  allograft  rejection,  and  GVH reactions toward 
determinants  on the  injected cells,  but show only a  limited  depletion of cells 
reactive in MLR. 
Materials  and  Methods 
Mice.  The following highly inbred strains of mice were used: CBA/J (H-2k),  CBA/Ca (H-2k), 
DBA/2 (H-2d), C57BL/6  (C57BL)  (H-2b), and FI crosses between CBA/J or CBA/Ca and C57BL or 
DBA/2 and between C57BL and DBA/2. The experiments shown in Table I and Figs. 1, 2, and 4 
(using CBA/J mice) were performed at the Basel Institute for Immunology using mice bred locally 
and derived originally  from The Jackson Laboratories,  Bar  Harbor,  Maine.  The experiments 
shown in Tables II, IV, V, and Fig. 3 (using CBA/Ca mice) were performed at University College 
London with mice derived originally from The Jackson Laboratories. The experiment shown in 
Table III was carried out at the Walter and Eliza Hall Institute; the origin of the mice used in this 
experiment has been described elsewhere (4). All mice were bred and housed under conventional 
conditions. 
Cell Suspensions.  Suspensions of thymus and spleen cells were prepared as described in the 
first paper of this series (4). TDL were collected by the method of Sprent (10). Cell viability was 
measured by dye exclusion. 
Injections.  All cell suspensions and radioisotopes were injected intravenously via the tail vein 
unless stated otherwise. 
Media.  For experiments not involving culture in vitro, Dulbecco's solution (11) was used. 
Irradiation.  Mice were exposed to whole body X-irradiation as previously described (4). A dose 
of 800 R was used unless stated otherwise. Spleen cells were irradiated {1,000 R) at 4°C. 
Injection oflrradiated  Spleen Cells.  After irradiation, spleen cells were cultured for 5 h  in 
vitro at 37°C in HEPES-buffered RPMI 1640 medium with 10% added fetal calf serum in 5% CO.~. 
Despite irradiation, the cells showed little loss of viability when harvested after this period of 
incubation; viability was usually in the range of 50-60%.  In most experiments, 6  ×  108  viable 
cultured spleen cells were injected intravenously; 3  ×  108 cells were injected immediately after 
harvest and the remainder 20-30 min later. The mice tolerated these injections surprisingly well 
and deaths were rare. In some experiments, a  similar dose of nonirradiated noncultured spleen 
cells was injected. Deaths after intravenous injection of  these cells were common, and the cells had 
to be given in three divided doses over 90 min or more. 
Antisera.  CBA anti-C57BL and CBA anti-DBA/2 alloantisera were raised by injecting CBA/J 
mice with C57BL and DBA/2 spleen cells, respectively. The spleen cells were injected intraperito- 
neally in a dose of 2 x  107 cells at fortnightly intervals. Serum was obtained 10-14 days after the 
last of six injections. A similar regime was used to prepare C57BL  anti-CBA serum. Anti-0 C3H 
antiserum was raised by the method of Reif and Allen (12). Serum was obtained after the 10th 
injection of thymus cells. 
Cytotoxic  Testing.  The dye exclusion method of Boyse et al.  (13) was used employing guinea 
pig serum as a source of complement. 
Skin  Grafting.  Mice  were  grafted  with skin  according to  the  method  of Billingham  and 
Medawar (14). 
Preparation  of Thymectomized,  Irradiated,  and  Marrow-Protected (TxBM)  Mice.  CBA  mice 
were thymectomized  at 6-8 wk of age by the method of Miller (15). The mice were irradiated (900 R) 
3-5  wk  later  and  protected with 3-5  x  10  ~ bone  marrow cells treated with anti-0 serum  and 
complement before intravenous injection. Skin grafts were applied 4-6 wk after irradiation. 
Mixed Lymphocyte Reaction.  (a) In vivo: The method of Sprent and Miller (16) was used. This 
technique involves measuring DNA synthesis in the spleen of irradiated F~  mice injected with 
parental strain T cells. Briefly, CBA TDL were transferred intravenously into irradiated semiallo- 
geneic or syngeneic mice. An intravenous injection of 25  ~Ci tritiated thymidine (3HTdR)  was 
given  at  various  intervals after cell  injection,  and  the  mice were killed  45  min  later.  Total 
radioactivity in the spleen was then measured as  described elsewhere (16).  (b)  In  vitro:  The 
method used was essentially that described by Nabholz et al. (17). TDL were washed three times, J.  SPRENT  AND  J.  F.  A.  P.  MILLER  587 
and aliquots of 2.5  x  10  ~ cells (responders) were cultured with 10  ~ mitomycin C-treated (18) spleen 
cells as stimulators in RPMI 1640 medium supplemented with 5% normal human serum, gluta- 
mine, 2-mercaptoethanol (3  x  10 -~ M), crystamyin (200 U of penicillin/ml), and bicarbonate (3.9 g/ 
liter).  The  cells  were  cultured  at  37°C in  Linbro  microtrays 1S-FB-96  (Linbro  Medlabs  Ltd., 
Dublin, Eire) in 10% CO2 in air.  3HTdR  incorporation was measured by washing the harvested 
cells through filter papers and extracting radioactivity with 0.5 ml Soluene (Packard Instrument 
Co., Downers Grove, Ill.) After adding scintillation fluid, radioactivity was measured in a liquid 
scintillation spectrometer (Packard Instrument Co.). 
GVH Assay.  The ability of parental strain cells to induce splenomegaly in neonatal F~ mice 
was determined according to the method of Simonsen (19). Intraperitoneal injections were given 
within  1-2  days  of birth,  and  the  spleen  weights determined  10  days  later.  Splenic  indices 
exceeding a  value of 1.5 were considered significant. 
CML.  After washing three times by centrifugation, aliquots of 3 x  10" TDL were cultured with 
mitomycin C-treated (18) (C57BL  x  DBA/2)F~ spleen cells for 6 days at 37°C in 10 ml Falcon 3013 
plastic tubes. The medium used was identical to that for the in vitro MLR assay except that it 
contained fetal calf serum (10%) instead of human serum. After harvest, the cultured cells were 
washed twice and incubated for 4 h at various ratios with 3 x  104 ~Cr-labeled target cells in small 
plastic tubes at a  final volume of 0.3 ml. 
Tumor Cells.  DBA/2 mastocytoma cells (PS15-X2) and C57BL EL4 cells were passaged in vivo 
through DBA/2  and  C57BL  mice, respectively. To  prepare target cells, tumor cells (107) were 
incubated with 200 mCi Na2 ~CrO4 in 1 ml for 30 min at 37°C and washed three times before use. 
Results 
Reactivity  of TDL from Mice Recently  Injected  with Irradiated SemiaUoge- 
neic Spleen  Cells 
In  previous  studies,  ASRL of GVH-reactive cells  was  induced  by injecting 
mice with normal (nonirradiated) semiallogeneic spleen cells (1). An objection to 
this approach is that a proportion of the injected cells presumably recirculate, at 
least initially, and thereby contaminate the host TDL. Since this contamination 
might interfere with the response of the TDL, it was considered important in the 
present study to ensure that the injected spleen cells did not recirculate.  The 
procedure adopted was to irradiate spleen cells in vitro and then culture the cells 
at 37°C for several hours before intravenous injection (see Materials and Meth- 
ods). This treatment has previously been shown to allow the cells to localize in 
the spleen but to prevent migration to lymph nodes, i.e., to regions traversed by 
recirculating lymphocytes (20). 
In initial experiments (data not shown), CBA mice were injected with 2 x  108 
irradiated  semiallogeneic spleen cells. This cell dose specifically abolished the 
capacity  of TDL  collected  1  day  later  to  produce  a  GVH  reaction  against 
determinants  present on the injected spleen cells. The response of the TDL in 
MLR, however, was reduced by only two to threefold.  Since complete ASRL to 
antigens such as heterologous erythrocytes is observed only when the antigen is 
injected in large doses (2), it was decided to increase the number of spleen cells 
injected by threefold. 
Unless stated otherwise, all the results considered below were obtained with 
TDL from CBA mice injected intravenously with 6 x  108 viable irradiated (1,000 
R) semiallogeneic or syngeneic spleen cells cultured in vitro at 37°C for 5-6 h 
before intravenous  injection.  In most experiments,  thoracic duct fistulas were 
established in the recipients 1 day later and TDL collected between 28 and 40 h. 
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TABLE  I 
Identity of TDL from CBA Mice Injected with Irradiated (CBA  × C57BL)F, or (CBA  x 
DBA/2)F, Spleen Cells 1 Day Previously 
Source of TDL 
Cytotoxic indices with:* 
CBA anti-DBA/2  CBA anti-  C57BL anti- 
serum  C57BL serum  CBA serum 
CBA mice given irradiated 
(CBA  x  C57BL)F, spleen 
1  98 
CBA mice given irradiated 
(CBA x  DBA/2)F, spleen 
0  -  100 
Normal (CBA  x  C57BL)F~  mice  99  99 
Normal (CBA  x  DBA/2)F, mice  I00  -  i00 
* TDL collected  28-40 h after  intravenous injection  of  6 × 108 viable irradiated spleen cells.  TDL 
were incubated with antiserum (1:4  dilution)  at  5 × 10"  cells/ml  at  37°C for  30  rain,  washed twice, 
and then incubated with complement (1:8  dilution);  viability  was assessed with eosin. Lysis in 
the presence of  antiserum alone, complement alone, or with normal mouse serum and comple- 
ment was <10%. 
ate alloantisera in the presence of complement. It can be seen from Table I that, 
in  the  case  of TDL from recipients of (CBA  ×  C57BL)F,  spleen  (henceforth 
referred to as "C57BL --~ CBA TDL"), virtually no cells were susceptible to lysis 
by CBA anti-C57BL antiserum.  Similarly DBA/2 --*  CBA TDL were entirely 
resistant to  lysis by  CBA  anti-DBA/2  serum.  These data  indicated that the 
injected irradiated spleen cells did not reach the central lymph of the host. 
GVH  REACTION.  TDL  were  transferred  to neonatal  F,  hybrid  mice  and 
splenic indices measured 10 days later.  CBA  --*  CBA TDL (TDL from recipients 
of syngeneic spleen) gave high splenic indices in both (CBA  x C57BL)F,  and 
(CBA x DBA/2)F, mice, significant  splenomegaly being observed with as  few as 
0.3 x 106  TDL (Fig.  1). By contrast,  C57BL --*  CBA TDL, though evoking strong 
responses in (CBA x DBA/2)F, mice, failed  to  produce splenomegaly in (CBA x 
C57BL)F, mice even in doses as high as 3 x 106  TDL. Similarly, DBA/2 --* CBA 
TDL responded well against C57BL determinants, but not against DBA/2 deter- 
minants. Two other experiments gave similar results. 
MLR. The capacity of  TDL to produce an MLR  was tested in vivo by transfer- 
ring graded numbers of  cells  to irradiated (800  R) mice of  different  strains.  The 
recipients  were killed  5 days later,  45 min after  intravenous injection  of  SHTdR, 
and levels of radioactivity were measured  in the spleen  (see Materials and 
Methods).  CBA  --* CBA  TDL  gave  high proliferative responses  MLR  both 
against  C57BL  and  DBA/2  determinants,  i.e.,  when  transferred to  (CBA  x 
C57BL)F,  and  (CBA  x  DBA/2)F,  mice,  respectively (Fig.  2).  These responses 
were directly proportional to the number of TDL injected. Significantly, C57BL 
--* CBA TDL also responded against C57BL determinants, although the magni- 
tude  of the response was reduced by 55%  (compared to that of CBA --~  CBA 
TDL). There was no reduction in the response of C57BL --* CBA TDL against 
third-party (DBA/2) determinants. Reciprocal results were obtained with DBA/2 J.  SPRENT  AND  J.  F.  A.  P.  MILLER  589 
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FIG. 1.  Splenic indices  in  (a)  (CBA x  C57BL)F~ and (b)  (CBA x  DBA/2)F~ mice injected  10 
days previously (at  birth)  with  varying numbers of  C57BL --,  CBA TDL (@),  DBA/2 --*  CBA 
TDL (©), or CBA ~  CBA  TDL (×).  The three TDL populations were collected  at 28-40 h 
after  injecting  CBA mice with 6 × 10  s  viable  irradiated  semiallogeneic or syngeneic spleen 
cells.  Each point  represents arithmetic mean (_+SE)  of  data from six to eight mice. 
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FIG. 2.  SHTdR incorporation in  spleens  of  irradiated  (a)  (CBA × C57BL)F~ and (b)  (CBA x 
DBA/2)F~ mice injected 5 days previously with varying numbers CBA  --* CBA TDL  (0), 
C57BL --*  CBA TDL (©),  DBA/2 --*  CBA TDL (D),  or normal syngeneic TDL (l).  The three 
CBA TDL populations were collected  at  28-40 h after  intravenous injection  of  6 x 10  s  viable 
irradiated semiallogeneic  or syngeneic  spleen cells. Radioactivity measured in spleens 
removed  45 rain after intravenous  injection  of 25 #Ci 3HTdR.  Each point represents 
arithmetic mean (-+SE) of  data from 4-5 mice. 
-* CBA TDL, i.e., there was a significant though reduced response against the 
specific (DBA/2) determinants and a near normal response against third-party 
(C57BL)  determinants.  Transfer  of the  three  TDL  populations  to  syngeneic 
(CBA) mice produced no response, i.e., 3HTdR incorporation was no higher than 
in mice not given cells (data not shown). 
Four other experiments gave essentially  similar findings.  In no experiment 
was there more than a 70% reduction in the response against the determinants 
on the injected spleen cells.  Responses against third-party  determinants  were 590  SELECTIVE  RECRUITMENT  OF  SUBSETS  OF  H-2-REACTIVE  T  CELLS 
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FIG. 3.  MLR measured in vitro of (a) CBA ---) CBA TDL, (b) C57BL --* CBA TDL, and (c) 
DBA/2 ~  CBA TDL; TDL populations collected at 28-40 h after intravenous injection of 6 x 
108 viable irradiated semiallogeneic or syngeneic spleen cells. The stimulating cells (mite- 
mycin C-treated spleen cells) were from (CBA × C57BL)F~ (x), (CBA x DBA/2)F1 (O), and 
CBA (0) mice. 3HTdR was added to cultures 18 h before harvest. Each point represents 
mean levels of radioactivity (_+SE) from triplicate cultures. 
generally  slightly  reduced,  although  this  was statistically  significant  in  only 
one experiment. 
Essentially  similar results were obtained when MLR was measured  in  con- 
ventional mixed lymphocyte culture in vitro. As shown in Fig. 3, C57BL --* CBA 
TDL gave a  definite proliferative response against  C57BL determinants  when 
measured at either day 3, 4, or 5 culture. At 3 and 4 days the response was three 
to fourfold less than to third-party (DBA/2) determinants. At 5 days no reduction 
was observed; this  was probably an artifact inasmuch  as the response against 
DBA/2  determinants  declined  between  day  4  and  day  5,  presumably  as  a 
consequence of overcrowding of the cultures.  DBA/2 --* CBA TDL gave recipro- 
cal results, the response against DBA/2 determinants being three to fourfold less 
than that against C57BL determinants on day 3 and 4, but virtually identical on 
day 5. 
The  experiment  illustrated  in  Fig.  4  examines  both  the  kinetics  and  the 
magnitude  of MLR given  by TDL collected  at  various  times  after spleen  cell 
injection. TDL were collected over 16 h from groups of the recipients at 1, 2, 3, or 
6 days later,  and MLR were measured in vivo. 
CBA -* CBA TDL collected at either 1 or 3 days after spleen cell transfer gave 
a strong MLR both against C57BL and DBA/2 determinants (Fig. 4). Responses 
were not detectable on day 2 of assay, but rose steeply thereafter and reached a 
peak on day 6. Similarly, a high response of normal kinetics was observed when 
C57BL --* CBA TDL collected at  1,  2,  3, or 6 days posttransfer were exposed to 
third-party (DBA/2) determinants.  Different results were obtained when these 
cells were exposed to the  specific (C57BL)  determinants.  With  C57BL --) CBA 
TDL collected on day 1, the MLR against C57BL determinants,  though reduced 
in magnitude by about 50%, showed normal kinetics.  With C57BL --* CBA TDL 
collected  at  2,  3,  or 6  days,  however,  both  the  magnitude  and  kinetics  of the 
response  changed.  All  three  populations  gave definite  responses  on  day  2  of 
assay. Maximal responses were observed on day 4 of assay rather than on day 6, J.  SPRENT  AND  J.  F.  A.  P.  MILLER  591 
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FIG.  4.  3HTdR incorporation in spleens of irradiated (CBA × C57BL)F~ and (CBA × DBA/ 
2)FI mice injected 2, 4, or 6 days previously with CBA --* CBA TDL or C57BL --* CBA TDL (5 
×  105 TDL given intravenously); 25 ~Ci 3HTdR was given 45 rain before removing spleens. 
The C57BL --* CBA TDL were collected at 1, 2, 3, or 6 days (a, b, c, d) after injecting CBA 
mice with 6 × 10  ~ irradiated (CBA × C57BL)Ft spleen cells; CBA --* CBA TDL were collected 
at 1 or 3 days (a, c) after injecting CBA mice with syngeneic irradiated spleen cells. Data 
shown: response of C57BL --* CBA TDL in (CBA x  C57BL)F~ (O) and (CBA x  DBA/2)F1 (O) 
mice; response of CBA --* CBA TDL in (CBA  x  C57BL)F~ ([3) and (CBA  x  DBA/2)F~  (B) 
mice; response of syngeneic TDL in (CBA ×  C57BL)F~ (A) and (CBA x  DBA/2)F~ (&) mice. 
Each point represents arithmetic mean of data from 4-6 mice; SE were within 10-15%  of 
mean. 
particularly with later TDL collections. In the case of  TDL collected at day 3, the 
response against C57BL determinants was higher at each stage of assay than 
that of CBA --* CBA TDL. 
The above data showed that the reduction in the capacity of TDL to produce 
an MLR against determinants on the injected spleen cells was maximal at day 1 
posttransfer.  The  fact that  this  reduction was  incomplete  might have  been 
related to the irradiation of the injected spleen cells. To investigate this possibil- 
ity, similar experiments were performed with mice given 6 ×  108 nonirradiated 
spleen cells; the cells were not cultured in vitro before injection. Among the 
TDL collected from CBA mice 1 day after injection of the above dose of nonirra- 
diated (CBA x  C57BL)FI spleen cells, 12-25% were susceptible to lysis by CBA 
anti-C57BL alloantiserum. This proportion of the TDL was therefore derived 
from the injected spleen cells. Table II shows the MLR measured in vivo of TDL 
collected at 28-40  h; the cells were treated with CBA anti-C57BL serum and 
complement before  injection.  It  is  evident that the  response  against  C57BL 
determinants was  reduced by only 41%  compared to TDL from recipients  of 
syngeneic spleen  cells.  Both populations of TDL gave  comparable  responses 
against DBA/2 determinants. Similar results were obtained in two other experi- 592  SELECTIVE  RECRUITMENT  OF  SUBSETS  OF  H-2-REACTIVE  T  CELLS 
TABLE  II 
Proliferative Response In Vivo of TDL from CBA Mice given Nonirradiated CBA or (CBA  x 
C57BL)F~  Spleen Cells 1 Day Previously 
3HTdR incorporation (  x 10  -3 _+ SE) in:$ 
Group  Viable cells trans-  Irradiated  Reduc-  Irradiated  Reduc- 
ferred* (4  ×  10  ~)  Irradiated  tion corn-  tion com- 
CBA  (CBA  x  (CBA  x  DBA/  pared to 
C57BL)F~  pared to  2)F~ 
group 2  group 2 
1  -  2.1  -+  0.2  2.6  -+  0.2 
2  TDL  from  CBA  1.9  _+  0.1  25.4  -+  0.8 
mice  given  CBA 
spleen  1  day  be- 
fore 
oh 
2.7  -+  0.2 
34.0  -+  1.2 
3  TDL  from  CBA  2.0  -+  0.1  16.1  _+  0.6  41  33.3  -+  1.0  2 
mice given (CBA 
x  C57BL)F, 
spleen  1  day  be- 
fore 
* TDL collected  28-40 h after intravenous injection  of  6 × 108  viable spleen cells;  spleen cells  were not cultured in  vitro 
before injection. Before transfer to irradiated mice, both TDL  populations were treated with CBA  anti-C57BL 
alloantiserum and complement before injection,  as described in footnote to Table I. 
Responses measured at 5 days after  intravenous transfer of  4 × 1{~  ~  TDL. Each value represents  the arithmetic mean 
levels  of  radioactivity in the spleen removed 45 rain after  intravenous injection  of  25 ~Ci 3HTdR; 4-6 mice per group. 
ments; in one, the responses were also measured in vitro. In neither experiment 
were MLR against the injected determinants reduced by more than 60%. 
SKIN ALLOGRAFT  REJECTION.  CBA mice injected with 6 x  108 irradiated and in 
vitro-culture (CBA  x  C57BL)F1  spleen cells were cannulated  1 day later,  and 
TDL were collected over the next 16 h. From 1-20  x  106 TDL were injected into 
TxBM CBA mice.  Within 2 h  the recipients were grafted with skin from both 
C57BL and BALB/c mice. In control experiments, skin-grafted TxBM mice were 
injected  with  TDL from normal  CBA  mice.  No  rejection  of either  C57BL  or 
BALB/c grafts was observed with TxBM mice not injected with TDL (Table III). 
TDL from normal CBA mice caused rapid rejection of both grafts even when low 
cell doses were used. Thus, 50% of the grafts were rejected within 21 days when 
as few as 10" TDL were given.  C57BL --* CBA TDL had only a  limited capacity 
to reject C57BL grafts. Even when as many as 2 x  107 TDL were injected, grafts 
on three out of eight mice survived for at least 40 days; the grafts at this stage 
were healthy and carried luxuriant tufts of hair. From the data in Table III it is 
evident that the pattern of rejection of C57BL grafts by 10  ~ normal CBA TDL 
was similar to that shown by 1-2  ×  107 C57BL --* CBA TDL, i.e., a  10-20-fold 
difference in  cell numbers.  In contrast to  C57BL grafts,  C57BL --)  CBA  TDL 
were effective at rejecting BALB/c grafts. With cell doses exceeding 10  ~ TDL, all 
grafts were rejected within  21  days.  The tempo of rejection of BALB/c grafts, 
however, was slightly slower with C57BL --* CBA TDL than with normal CBA 
TDL (e.g., with transfer of 107 cells) (Table III). 
CML.  TDL collected 28-40 h  after injection of 6  x  108 irradiated and in vitro 
cultured (CBA  x  C57BL)F~ spleen cells were cultured for 6 days in vitro with 
mitomycin C-treated (C57BL x  DBA/2)F1 spleen cells as stimulators (see Mate- J.  SPRENT  AND  J.  F.  A.  P.  MILLER  593 
TABLE III 
Capacity of TDL to Cause Rejection  of Skin Allografts on TxBM CBA Mice: Reactivity of TDL 
from CBA Mice Injected with Irradiated (CBA  x  C57BL)F~ Spleen Cells 1 Day Previously 
Number of mice showing following skin graft survival:$ 
Number 
TDL trans-  Number of  of TxBM  C57BL  BALB/c 
ferred*  TDL injected  recipi- 
ents  10-15  16-20  10-15  16-20 
>21 days  >21 days 
days  days  days  days 
Normal  CBA  -  5  -  -  5  -  -  5 
TDL  l0  s  7  1  3  3  1  2  4 
5  x  l0  s  5  3  2  -  3  2  - 
107  5  5  -  -  5  -  - 
TDL  from  CBA  10  ~  14  -  2  12  1  4  9 
mice  given  5  x  10  ~  10  -  2  8  3  7  - 
(CBA  ×  107  9  2  3  4  4  5  - 
C57BL)F~  2  ×  107  8  2  3  3  4  4  - 
spleen 
* TDL collected 24-40 h  after intravenous injection of 6  x  10  ~ viable irradiated spleen cells. 
* Skin grafts applied within 2 h  of injecting TDL. 
rials and Methods). The cultured TDL were then harvested and incubated for 4 h 
in vitro at various ratios with 5~Cr-labeled  EL4 (C57BL)  tumor cells or P815 
(DBA/2)  mastocytoma cells. "Activated" CBA --, CBA TDL caused effective de- 
struction of both types of target cells, significant lysis being detected with lym- 
phocyte:target cell ratios as low as 2:1 (Table IV).  C57BL ~  CBA TDL were also 
effective at lysing the DBA/2 tumor, but did not cause detectable lysis of the 
C57BL targets even at ratios as high as 50:1. Mixing the two cultured popula- 
tions together during incubation with the target cells did not impair the capacity 
of the  CBA --*  CBA TDL to  lyse the C57BL tumor.  Results similar to those 
shown in Table IV were obtained in two other experiments (data not shown); in 
one experiment, phytohemagglutin-transformed  spleen cells, as well as the two 
tumor cell populations, were used as targets. 
Reactivity  of TDL from Irradiated F1 Mice Recently Injected  with Parental 
Strain Lymph Node Cells.  The preceding data raised the question of whether 
irradiated cells under any circumstances could induce complete ASRL of cells 
involved in the MLR. Accordingly, it was decided to investigate the reactivity of 
parental strain T cells filtered from blood to lymph through irradiated F1 mice. 
10 (CBA x  C57BL)F~ mice were exposed to 1,000 R and then, within 1 h, injected 
intravenously with 108 mesenteric lymph node (MLN) cells from normal CBA 
mice; 72% of these cells were 0-positive. The mice were cannulated 12 h  later, 
and TDL was collected at various intervals over the next 3 days. Between 18 and 
40  h  aider injection the  lymph contained very few  cells  (3-5  ×  10~/12 h  per 
mouse).  Of these cells  <0.5% were blasts,  <5% were of host origin, i.e.  were 
susceptible  to  lysis  by  CBA  anti-C57BL  antiserum,  and  nearly  all  were  T 
lymphocytes (98% 0-positive). Blast cells were first detected in the lymph at 44- 
48 h  and by 60-72  h  accounted for nearly all of the lymph-borne cells. At this 
stage, total cell outputs reached as high as 3 x  107/12 h per mouse. Of these cells, 
<2% were of host origin and >98% were 0-positive. 
Testing the proliferative capacity of the cells in vivo showed that pooled TDL 
collected at intervals between 18 and 48 h gave no detectable response to host- 594  SELECTIVE  RECRUITMENT  OF  SUBSETS  OF  H-2-REACTIVE  T  CELLS 
TABLE  IV 
Capacity of TDL to Differentiate into Cytotoxic Lymphocytes during Culture in vitro with 
C57BL and DBA/2 Determinants: Reactivity of TDL from CBA Mice Injected with 
Irradiated (CBA  × C57BL)F~  or CBA Spleen Cells 1 Day Previously 
CBA TDL* cultured in vitro for 6 
days with mitomycin C-treated 
(C57BL  ×  DBA/2)Fj  spleen cells 
Specific ~Cr-release with:$ 
Lymphocyte:target  P815 mastocy- 
cell ratio  EL4 (C57BL) tar- 
toma (DBA/2) 
gets 
targets 
TDL from mice given CBA 
spleen 
% 
50:1  72.3  42.1 
25:1  54.9  31.7 
10:1  41.8  17.2 
2:1  13.8  12.0 
TDL  from  mice 
(CBA  ×  C57BL)F~ 
spleen 
given  50:1  0.5  37.2 
10:1  -3.3  13.1 
2:1  -0.3  5.4 
TDL from mice given CBA  25 I 
spleen  : 1 
+  25) 
TDL  from  mice  given  l:t 
(CBA  x  C57BL)F~  :1 
spleen  10) 
51.5  37.9 
30.1  14.7 
* TDL collected 28-40 h  after intravenous injection of 6  ×  108 viable irradiated spleen cells.  For 
conditions of culturing TDL with mitomycin C-treated stimulators, see Materials and Methods. 
$ After activation in vitro, lymphocytes were cultured with 3 x  104 target cells for 4 h. Each value 
represents mean of triplicate cultures; SE  were within 10% of mean.  Spontaneous release  of 
5~Cr from EL4 was 9% and from P815,  11%. 
type  (C57BL)  determinants  at  either  day  2  or  5  of assay  (Table  V).  High 
responses, however, were observed against third-party (BALB/c) determinants 
(demonstrable on day 5 though not on day 2). With TDL collected at 64-72 h, i.e. 
cells consisting almost entirely of blast T cells (vide supra),  low but significant 
responses were observed against both sets of determinants. The responses were 
higher on day 2 of assay than day 5 and higher against C57BL than BALB/c 
determinants. No responses were obtained when the cells were transferred to 
syngeneic (CBA) mice (data not shown). 
TDL from normal CBA mice gave high late responses against both sets of 
determinants, definite responses being observed with as few as 10  '~ cells.  With 
respect to C57BL determinants, it is to be noted that the '~filtered" MLN cells 
were totally unresponsive even with cell numbers as high as 106 . 
Discussion 
By parameters other than the MLR, TDL collected from mice injected 1 day 
previously with 6  ×  108 irradiated and in vitro cultured semiallogeneic spleen 
cells were specifically depleted of lymphocytes reactive to the H-2 determinants 
on the injected cells.  For GVH reactivity the depletion was  >10-fold, for skin J.  SPRENT  AND  J.  F.  A.  P.  MILLER  595 
TABLE  V 
Proliferative Response of TDL from Irradiated (1,000 R) (CBA  x  C57BL)F~ Mice 
Injected Intravenously  with 10 H  CBA Mesenteric Lymph Node Cells 
SHTdR incorporation (x i0  -s) (-4-  SE) in:* 
Time of col- 
lection of  Number of  Irradiated (CBA  x  Irradiated (CBA  ×  Cells assayed 
passaged  TDL  C57BL)F~  BALB/c)F~ 
MLN cells 
at 2 days  at 5 days  at 2 days  at 5 days 
TDL  from  ir- 
radiated 
(CBA  x 
C57BL)F~ 
mice  in- 
jected  with 
10  ~  CBA 
MLN  cells 
Normal CBA 
TDL 
18-24 h 
24-40 h 
40-48  h 
64 -  72  h 
5  x  105  0  0.1  0  21.6 
2  x  10:'  -  0  -  9.0 
5  x  10  ~  0  0.1  0.1  14.5 
1  ×  10  ~  -  0  -  22.0 
5  ×  10  :~  0  0  0  10.0 
5  x  10:'  6.5  3.7  3.8  1.9 
1  x  10  ~  -  4.6  -  4.5 
2  x  10  ~  -  9.1  -  8.4 
5  x  10  '~  0.4  19.2  0.5  17.8 
1  x  10  ~  -  26.8  -  30.2 
* Each number represents arithmetic mean of radioactivity levels in spleen 45 min after injection 
of 25  ~Ci  aHTdR.  For simplicity,  background value present in irradiated  mice given no cells 
have been subtracted. 4-6 mice per group. SE were within 10% of the mean. Responses observed 
with TDL collected at 64-72 h  were all significantly above background levels (P values ranging 
from <0.005 to <0.05). 
allograft rejection 10-20-fold, and for CML >25-fold (calculated from data in Fig. 
1, Tables III and IV, respectively). Reactivity against third party determinants 
was usually not significantly reduced. Whether the use of such massive doses of 
spleen cells is essential to achieve the degree of depletion observed has yet to be 
investigated.  It  may  be  added  that  the  cell  dose  used  caused  no  detectable 
decrease in TDL outputs (unpublished data). 
With  regard  to  GVH  reactivity,  recent  experiments  have  shown  that  the 
unresponsiveness  affecting  TDL  does  not  apply  to  cells  recovered  from  the 
spleen (unpublished data of the authors).  This, together with previous evidence 
that TDL regain their reactivity after 3 days (1), is consistent with the hypothe- 
sis that the transient  unresponsiveness observed with TDL at 1-2 days in the 
present study was the result of ASRL to organs such as the spleen. ASRL would 
also seem the most likely explanation for the unresponsiveness detected towards 
determinants  controlling  skin  allograft  rejection  and  CML.  In  this  respect, 
preliminary  studies  have  indicated  that  the  unresponsiveness  towards  CML 
determinants does not apply to (a) spleen cells removed on day 1 after allogeneic 
cell transfer or (b) TDL collected on day 5. It should be emphasized that in the 
case of CML there was no evidence that the unresponsiveness of TDL collected 
on day 1 resulted from active suppression (Table IV). 
The failure to produce in TDL more than a partial depletion of cells reactive to 596  SELECTIVE  RECRUITMENT  OF  SUBSETS  OF  H-2°REACTIVE  T  CELLS 
MLR determinants was unexpected. In no experiments did the degree of deple- 
tion exceed fourfold, and in most experiments it was only two to threefold. The 
possibility  that  the  restriction  in  the  degree  of depletion  observed reflected 
destruction and loss of immunogenicity of the injected spleen cells due to their 
prior irradiation  is unlikely,  since similar results were obtained with nonirra- 
diated spleen cells (Table II). The present findings contrast with reports of other 
workers.  In  sheep,  it  was found that  within  2-3  days of injecting  allogeneic 
lymphocytes into the draining  area of the popliteal lymph node, cells collected 
from the efferent lymphatics of the injected node and also from the contralateral 
node  were completely devoid of cells reactive to the injected determinants  in 
MLR (21). In rats, peripheral blood lymphocytes taken shortly after intravenous 
injection of low doses of allogeneic spleen cells (e.g.  3  x  107) were profoundly 
unresponsive in MLR against the injected determinants  (22,  23). In contrast to 
the present findings and those in sheep (21) (both using lymph-borne cells), the 
unresponsiveness observed in rats lasted for several weeks; this was shown to be 
due in part to the presence of blocking factors (23). 
Our observation that the residual activity of 'selected' TDL populations was 
directed  solely towards  MLR determinants  is  consistent  with  evidence  that 
lymphocytes reactive  to  MLR determinants  have  a  different  specificity from 
those controlling CML and skin allograft rejection (6, 7, 9, 24, 25). To account for 
the dichotomy in the  ability of "selected" TDL to respond in MLR but not to 
evoke GVH reactions, however, is more difficult since, as mentioned in the intro- 
duction, the (/-region) determinants which control these two reactions are gener- 
ally considered to be identical.  One possibility is that the residual MLR exerted 
by the TDL was directed not against H-2 but M-locus (Mls) determinants  (26), 
i.e.,  determinants  that  do not evoke GVH reactions by the assay used in the 
present paper. This is unlikely because in the case of the response of CBA TDL 
to C57BL determinants  shown in Table II and Fig. 3,  CBA/Ca mice were used 
(see  Materials  and  Methods),  CBA/Ca  and  C57BL being M-locus compatible 
(Mls b) (ref. 26 and unpublished data of the authors). 
A  tentative  explanation  for  the  capacity  of "selected" TDL  populations  to 
respond  in  MLR,  but not to evoke GVH reactions,  is offered as follows.  It is 
suggested  that:  (a)  the  affinity  of lymphocytes  for/g-region-controlled  H-2 
determinants varies, both high- and low- affinity cells proliferating in MLR, but 
only high-affinity  cells being  able to  evoke GVH reactions  (splenomegaly in 
newborn mice); (b) ASRL after injection of  I-region-incompatible spleen cells in 
the present system affects only high-affinity cells, the low-affinity cells remain- 
ing in the circulation and thereby accounting for the residual capacity of TDL to 
proliferate  in  MLR,  but  not  to  evoke  GVH  reactions.  It  follows  from  this 
hypothesis that  ASRL of low-affinity cells would occur only after exposure to 
extremely high concentrations of the selecting determinants,  i.e.,  higher than 
can be administered intravenously. This prediction is consistent with the results 
of the experiments in which parental  strain T cells were filtered from blood to 
lymph through irradiated F1 hybrid mice, i.e., a situation where the hosts per se 
presented the selecting determinants  (Table V). Thus,  when CBA lymph node 
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origin,  2 which entered thoracic duct lymph 18-48 h later, produced no detectable 
MLR against C57BL determinants but responded well to third party (BALB/c) 
determinants. This system was originally described by Ford and Atkins (5) who 
observed that parental strain TDL filtered from blood to lymph through suble- 
thally  irradiated  AgB-incompatible  F1  rats  were  specifically devoid  of cells 
capable of evoking a GVH reaction (popliteal lymph node enlargement) against 
host-type determinants. These findings were subsequently confirmed by Dorsch 
and Roser (27) who made the additional observation that the filtered TDL were 
specifically depleted cells capable of rejecting host-type skin allografts. 
With both systems used in the present study, cells capable of responding in 
MLR against the sensitizing determinants re-entered the lymph after 2-3 days. 
This was associated with a  marked alteration in the kinetics of the response, 
particularly with cells recovered from irradiated FI recipients of parental-strain 
lymph node lymphocytes. In this situation, TDL recovered after 48 h produced 
an MLR that was clearly detectable on day 2 of assay, but was very low on day 5; 
similar results were obtained previously with lymph-borne cells recovered from 
irradiated F1 recipients of parental strain thymus cells (28). Since most of the 
cells in the lymph at times after 48 h were 0-positive blast cells, these findings 
imply that ASRL ceased after day 2, the activated progeny of the recruited cells 
then entering the lymph in large numbers and synthesizing DNA rapidly when 
re-exposed to the sensitizing determinants. 
Alteration in the kinetics of MLR was also a feature of late TDL collections 
from parental strain recipients of irradiated F1 spleen cells. For example, with 
TDL collected on day 4, the MLR against the sensitizing determinants (a) was of 
rapid onset, (b) peaked at 4 days (instead of 6 days with unstimulated TDL), and 
(c)  was  above  normal  in  amplitude  (Fig.  4);  similar  findings were reported 
previously for peripheral blood lymphocytes of rats sensitized subcutaneously 
(22). Interpreting these data concisely is clearly difficult. Perhaps the simplest 
explanation is  that only a  proportion of the cells that  re-entered the  lymph 
subsequent to ASRL at day 1 were in an activated state. Studies of Ford et al. 
(29) are relevant here. These workers observed that whereas 12% oflymphocytes 
transferred to irradiated AgB-incompatible rats were selectively recruited to the 
spleen, only 50% of these cells underwent blast transformation. It was suggested 
that  the  nontransformed  recruited  cells  might  have  been  of low  affinity. 
Whether these cells subsequently re-entered the circulation was  not investi- 
gated. 
Summary 
Information was sought on the reactivity of thoracic duct lymphocytes (TDL) 
from parental strain mice injected intravenously with large numbers of irradi- 
ated semiallogeneic spleen cells. TDL collected at 1 day after spleen cell injec° 
2 Of peripheral interest is the fact that whereas only 72% of the injected lymph node cells were 
0-positive, 0-positive lymphocytes accounted for 98% of the cells recovered from the lymph at 18-40 
h (>95% of these cells were of donor origin). This would appear to confirm previous findings that, 
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tion were almost totally depleted of lymphocytes able to produce cell-mediated 
lympholysis (CML), a graft-versus-host (GVH) reaction, and skin allograft rejec- 
tion against the H-2 determinants on the injected spleen cells.  Normal or near 
normal responses were observed against third-party determinants. In the case of 
CML,  there was no evidence that the unresponsiveness was due to suppressor 
cells. 
In marked contrast, the capacity of TDL to exert a specific mixed lymphocyte 
reaction (MLR) against the injected determinants was reduced by no more than 
two to fourfold; this applied whether MLR were measured in vivo or in vitro. 
Injection  of normal  rather  than  irradiated  semiallogeneic  spleen  cells  gave 
similar results.  Complete and specific removal of MLR-producing lymphocytes 
was achieved,  however, in a  different system in which parental  strain T  cells 
were filtered from blood to lymph through irradiated F, hybrid mice. Since this 
system presumably provided a  much higher concentration of H-2 determinants 
to the responding lymphocytes, it is suggested that the differing results obtained 
with these two systems may indicate that certain cells reactive to H-2 determi- 
nants are of low affinity, their reactivity being detected in the MLR, but not by 
other parameters.  With both systems, MLR-producing lymphocytes reappeared 
in  the lymph after 2-3  days; the cells collected at this  stage  gave an  MLR of 
altered kinetics. 
The present data,  in  toto,  suggest that  under certain  conditions  of antigen 
presentation, virtually all recirculating lymphocytes reactive to a given set of  H- 
2  determinants can be induced to leave the circulation for a period of 1-2 days. 
After responding to the injected determinants (presumably in organs such as the 
spleen), the cells re-enter the circulation in an activated state after 2-3 days. 
The excellent  technical  assistance  of Miss C.  Norbury  and  Miss J.  Gamble is  gratefully 
acknowledged. 
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